Xiaoli Ma

1.2k total citations
27 papers, 273 citations indexed

About

Xiaoli Ma is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Xiaoli Ma has authored 27 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Hepatology and 4 papers in Molecular Biology. Recurrent topics in Xiaoli Ma's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xiaoli Ma is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xiaoli Ma collaborates with scholars based in China, United States and Canada. Xiaoli Ma's co-authors include Semyon I. Aleynik, Maria K. Aleynik, C S Lieber, Maria A. Leo, Enrique Baraona, Yuejie Zheng, Jikui Deng, Hui Liu, Lanjia Lin and Phillip Dinh and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Xiaoli Ma

23 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Ma China 7 134 66 64 42 39 27 273
William H. Alarcon United States 6 175 1.3× 44 0.7× 129 2.0× 48 1.1× 95 2.4× 6 409
Amal M. H. Ghanim Egypt 10 60 0.4× 42 0.6× 45 0.7× 41 1.0× 122 3.1× 12 316
Amy M. Bataille United States 8 134 1.0× 60 0.9× 54 0.8× 100 2.4× 161 4.1× 10 396
Junli Zhang China 8 165 1.2× 25 0.4× 43 0.7× 29 0.7× 132 3.4× 19 348
Yingmei Tang China 10 127 0.9× 21 0.3× 84 1.3× 52 1.2× 123 3.2× 20 352
Liuying Chen China 10 140 1.0× 35 0.5× 87 1.4× 23 0.5× 127 3.3× 17 324
Fatma El Zahraa Ammar Mohamed Egypt 10 131 1.0× 17 0.3× 150 2.3× 34 0.8× 76 1.9× 23 341
John P. Kirchner United States 8 98 0.7× 54 0.8× 62 1.0× 44 1.0× 30 0.8× 12 295
Ruichao Yue China 14 214 1.6× 119 1.8× 23 0.4× 19 0.5× 236 6.1× 23 487

Countries citing papers authored by Xiaoli Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Ma more than expected).

Fields of papers citing papers by Xiaoli Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Ma. The network helps show where Xiaoli Ma may publish in the future.

Co-authorship network of co-authors of Xiaoli Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Ma. A scholar is included among the top collaborators of Xiaoli Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Ma. Xiaoli Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Juntao, et al.. (2025). Significant Influence of Abemaciclib on Rivaroxaban. Therapeutic Drug Monitoring. 47(3). 320–322.
2.
Zhao, Juntao, Xiaoli Ma, Shu Chen, et al.. (2025). Antibody-free quantification of serum infliximab using LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 266. 117117–117117.
3.
Grace, X., Lin Zhu, Yin Tan, et al.. (2023). A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus. Digestive Diseases and Sciences. 68(6). 2333–2343. 2 indexed citations
7.
Xiong, Xing, et al.. (2019). Effects of combination of mizolastine and proteoglycan on chronic urticaria: a randomized controlled trial. Archives of Dermatological Research. 311(10). 801–805. 4 indexed citations
8.
Buti, Marı́a, Namiki Izumi, Young‐Suk Lim, et al.. (2019). FRI-158-Bone and renal safety are improved in chronic HBV patients switched to tenofovir alafenamide (TAF) after either 2 or 3 years of prior tenofovir disoproxil fumarate (TDF) treatment. Journal of Hepatology. 70(1). e457–e458. 1 indexed citations
9.
Zhang, Xu, et al.. (2017). Correlation between 25-hydroxy-Vitamin-D and senile diabetic peripheral neuropathy in type 2 diabetes. Biomedical Research-tokyo. 28(14). 6286–6289. 1 indexed citations
10.
Chan, Henry Lik‐Yuen, Magdy Elkhashab, Huy N. Trinh, et al.. (2015). Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B. Journal of Hepatology. 63(5). 1086–1092. 51 indexed citations
11.
Ma, Xiaoli, et al.. (2015). HCV Screening Behaviors and Infection Status among Vietnamese Americans. American Journal of Health Behavior. 39(5). 640–651. 2 indexed citations
12.
Zhang, Qian, et al.. (2013). Response of reproductive allocation of Stellera chamaejasme population in alpine grassland to altitude. Shengtaixue zazhi. 32(2). 247–252. 4 indexed citations
13.
Ma, Xiaoli, et al.. (2013). Plasma thrombin-activatable fibrinolysis inhibitor levels and its Thr325Ile polymorphism in breast cancer. Blood Coagulation & Fibrinolysis. 24(7). 698–703. 7 indexed citations
14.
Zang, Li, Yiming Mu, Zhao-Hui Lu, et al.. (2011). [LRP16 gene causes insulin resistance in C2-C12 cells by inhibiting the IRS-1 signaling and the transcriptional activity of peroxisome proliferator actived receptor γ].. PubMed. 91(20). 1408–12. 2 indexed citations
15.
Ma, Xiaoli, et al.. (2010). Pollen Morphology and Viability of Elaeagnus umbellata. Zhiwu yanjiu. 30(1). 8–11. 1 indexed citations
16.
Ma, Xiaoli. (2008). Clinical Evaluation on Yanshu Injection plus Lentinan in the Treatment of Advanced Digestive Tract Cancer. 1 indexed citations
17.
Ma, Xiaoli, et al.. (1998). Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation. International Journal of Cardiology. 66. S57–S64. 9 indexed citations
18.
Aleynik, Semyon I., Maria A. Leo, Xiaoli Ma, Maria K. Aleynik, & C S Lieber. (1997). Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. Journal of Hepatology. 27(3). 554–561. 107 indexed citations
19.
Baraona, Enrique, Wei Liu, Xiaoli Ma, Gianluca Svegliati‐Baroni, & Charles S. Lieber. (1993). Acetaldehyde-collagen adducts in N-nitrosodimethylamine-induced liver cirrhosis in rats. Life Sciences. 52(15). 1249–1255. 21 indexed citations
20.
Ma, Xiaoli, Enrique Baraona, Jerome M. Lasker, & Charles S. Lieber. (1991). Effects of ethanol consumption on bioactivation and hepatotoxicity of N-nitrosodimethylamine in rats. Biochemical Pharmacology. 42(3). 585–591. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026